Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $2.77 billion. The enterprise value is $2.68 billion.
| Market Cap | 2.77B |
| Enterprise Value | 2.68B |
Important Dates
The last earnings date was Wednesday, July 29, 2026, before market open.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 53.76 million shares outstanding. The number of shares has increased by 9.28% in one year.
| Current Share Class | 53.76M |
| Shares Outstanding | 53.76M |
| Shares Change (YoY) | +9.28% |
| Shares Change (QoQ) | +3.39% |
| Owned by Insiders (%) | 2.12% |
| Owned by Institutions (%) | 100.46% |
| Float | 52.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 79.01 |
| PS Ratio | 11.02 |
| Forward PS | 9.12 |
| PB Ratio | 10.78 |
| P/TBV Ratio | 11.13 |
| P/FCF Ratio | 321.83 |
| P/OCF Ratio | 183.90 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 311.21 |
Financial Position
The company has a current ratio of 6.60, with a Debt / Equity ratio of 0.08.
| Current Ratio | 6.60 |
| Quick Ratio | 4.79 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.33 |
| Interest Coverage | -3.08 |
Financial Efficiency
Return on equity (ROE) is -18.21% and return on invested capital (ROIC) is -3.50%.
| Return on Equity (ROE) | -18.21% |
| Return on Assets (ROA) | -3.15% |
| Return on Invested Capital (ROIC) | -3.50% |
| Return on Capital Employed (ROCE) | -4.68% |
| Weighted Average Cost of Capital (WACC) | 10.58% |
| Revenue Per Employee | $403,817 |
| Profits Per Employee | -$53,936 |
| Employee Count | 622 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 1.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +218.90% in the last 52 weeks. The beta is 1.14, so Axogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +218.90% |
| 50-Day Moving Average | 44.74 |
| 200-Day Moving Average | 36.92 |
| Relative Strength Index (RSI) | 63.66 |
| Average Volume (20 Days) | 880,766 |
Short Selling Information
The latest short interest is 3.37 million, so 6.26% of the outstanding shares have been sold short.
| Short Interest | 3.37M |
| Short Previous Month | 4.07M |
| Short % of Shares Out | 6.26% |
| Short % of Float | 6.40% |
| Short Ratio (days to cover) | 3.16 |
Income Statement
In the last 12 months, Axogen had revenue of $251.17 million and -$33.55 million in losses. Loss per share was -$0.68.
| Revenue | 251.17M |
| Gross Profit | 187.27M |
| Operating Income | -12.85M |
| Pretax Income | -33.55M |
| Net Income | -33.55M |
| EBITDA | -5.97M |
| EBIT | -12.85M |
| Loss Per Share | -$0.68 |
Balance Sheet
The company has $111.41 million in cash and $20.07 million in debt, with a net cash position of $91.35 million or $1.70 per share.
| Cash & Cash Equivalents | 111.41M |
| Total Debt | 20.07M |
| Net Cash | 91.35M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 256.26M |
| Book Value Per Share | 4.78 |
| Working Capital | 170.00M |
Cash Flow
In the last 12 months, operating cash flow was $15.05 million and capital expenditures -$6.45 million, giving a free cash flow of $8.60 million.
| Operating Cash Flow | 15.05M |
| Capital Expenditures | -6.45M |
| Depreciation & Amortization | 6.88M |
| Net Borrowing | -48.62M |
| Free Cash Flow | 8.60M |
| FCF Per Share | $0.16 |
Margins
Gross margin is 74.56%, with operating and profit margins of -5.12% and -13.36%.
| Gross Margin | 74.56% |
| Operating Margin | -5.12% |
| Pretax Margin | -13.36% |
| Profit Margin | -13.36% |
| EBITDA Margin | -2.38% |
| EBIT Margin | -5.12% |
| FCF Margin | 3.42% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.28% |
| Shareholder Yield | -9.28% |
| Earnings Yield | -1.21% |
| FCF Yield | 0.31% |
Analyst Forecast
The average price target for Axogen is $53.90, which is 4.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $53.90 |
| Price Target Difference | 4.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 20.98% |
| EPS Growth Forecast (3Y) | 52.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 16.88 and a Piotroski F-Score of 4.
| Altman Z-Score | 16.88 |
| Piotroski F-Score | 4 |